taurine has been researched along with Ventricular Dysfunction, Left in 3 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the protective effect of subacute pre-adminsitration of either selenium (Se), taurine (Tau), or both drugs in combination against experimentally induced myocardial infarction (MI) in rats and illustrates the possible mechanisms of action." | 7.85 | A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats. ( Dallak, M, 2017) |
| "Supplementation results in higher myocardial CoQ10, taurine, and carnitine levels and is associated with a reduction in left ventricular end-diastolic volume in patients with left ventricular dysfunction before revascularization." | 5.10 | Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. ( Barr, A; Errett, L; Freeman, M; Jeejeebhoy, F; Keith, M; Kurian, R; Mazer, D; McCall, M, 2002) |
| "This study investigated the protective effect of subacute pre-adminsitration of either selenium (Se), taurine (Tau), or both drugs in combination against experimentally induced myocardial infarction (MI) in rats and illustrates the possible mechanisms of action." | 3.85 | A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats. ( Dallak, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallak, M | 1 |
| Xu, YJ | 1 |
| Saini, HK | 1 |
| Zhang, M | 1 |
| Elimban, V | 1 |
| Dhalla, NS | 1 |
| Jeejeebhoy, F | 1 |
| Keith, M | 1 |
| Freeman, M | 1 |
| Barr, A | 1 |
| McCall, M | 1 |
| Kurian, R | 1 |
| Mazer, D | 1 |
| Errett, L | 1 |
1 trial available for taurine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
Topics: Aged; Carnitine; Coenzymes; Dietary Supplements; Double-Blind Method; Female; Heart Failure; Humans; | 2002 |
2 other studies available for taurine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats.
Topics: Animals; bcl-2-Associated X Protein; Biomarkers; Disease Models, Animal; Drug Synergism; Electrocard | 2017 |
MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Calcium; Enzyme Activation; Enzyme-Li | 2006 |